117 results
D
ADVM
Adverum Biotechnologies Inc
21 Feb 24
$127.80 mm in equity / options, sold $127.80 mm, 20 investors
3:39pm
to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise
8-K
EX-99.2
1ly fyrk440w6o4b
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-99.1
a2nn2fbpc 14lqsvt19w
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-10.2
vqsvtyhw d1pj0a
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
CORRESP
103kj
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
rvzbz6v9 aziqc0
18 Dec 23
Letter from SEC
12:00am
424B5
2zeilvkg382rjcbtcrl
11 May 23
Prospectus supplement for primary offering
4:43pm